The company hasn’t submitted the data of phase 3 trials to the Central Drug Standard Control Organisation (CDSCO) yet, but interim data for the approval has been submitted by the company in the month of March. The company said that it has filed its phase 2 data with CDSCO in the month of January this year.
Bhardwaj, Shalini More than 21 lakh mRNA COVID-19 vaccine doses have been certified for stockpile by the Central Drugs Laboratory (CDL) in Kasauli. India has been stockpiling the Covid 19 mRNA vaccine. Gennova Biopharmaceuticals Ltd, based in Pune, makes this vaccine. According to the sources, the CDL Kasauli under the Health Ministry is in charge of ensuring the vaccine’s safety and efficacy.
Suggestion For You:
Gennova’s mRNA vaccine is an Omicron-specific vaccine and has already tweaked its mRNA platform that will target Omicron. ANI went further and generated some more queries to the company about the latest updates on data submitted to CDSCO but the company refused to answer.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week